WORST PROGNOSIS OF HYPOVASCULAR HEPATOCELLULAR CARCINOMA (HCC)

被引：3
|
作者：
Mayer, J. [1 ]
Auriol, J. [1 ]
Muscari, F. [2 ]
Carrere, N. [2 ]
Bournet, B. [3 ]
Bureau, C. [4 ]
Vinel, J. -P. [4 ]
Otal, P. [1 ]
Peron, J. -M. [4 ]
机构：
[1] Hop Rangueil, Serv Radiol, Toulouse, France
[2] Hop Rangueil, Serv Chirurg Digest, Toulouse, France
[3] Hop Rangueil, Serv Gastroenterol & Hepatol, Toulouse, France
[4] Hop Purpan, Serv Hepatogastroenterol, Toulouse, France
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60574-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] Prognosis of patients with metastatic hepatocellular carcinoma (HCC).
    Ishii, H
    Furuse, J
    Nagase, M
    Yoshino, M
    Takahashi, S
    Nakagohri, T
    Konishi, M
    Kinoshita, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 345S - 345S
  • [2] DIAGNOSTIC ALGORITHM FOR HEPATOCELLULAR CARCINOMA (HCC) IN HYPOVASCULAR NODULE OF THE LIVER; A MULTICENTER NATIONWIDE STUDY
    Izumi, N.
    Tsuchiya, K.
    Matsui, O.
    Sata, M.
    Kuromatsu, R.
    Moriyasu, F.
    Imai, Y.
    Aoyagi, Y.
    Iijima, H.
    Arii, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S388 - S388
  • [3] Radiofrequency Ablation for hypovascular hepatocellular carcinoma: comparison with hypervascular hepatocellular carcinoma
    Sakamoto, Azusa
    Takeda, Haruhiko
    Kanesaka, Takashi
    Nakajima, Jun
    Matsuda, Fumihiro
    Hatamaru, Keiichi
    Henmi, Shinichiro
    Saito, Sumio
    Nasu, Akihiro
    Nishikawa, Hiroki
    Kita, Ryuichi
    Kimura, Toru
    Osaki, Yukio
    HEPATOLOGY, 2012, 56 : 481A - 481A
  • [4] The characteristics of medium to large hypovascular hepatocellular carcinoma
    Lai, H-C.
    Chan, C-Y.
    Peng, C-Y.
    Liao, K-F.
    Lin, Z-Y.
    Huang, W-H.
    Chou, J-W.
    Yu, C-J.
    LIVER INTERNATIONAL, 2006, 26 : 68 - 68
  • [5] The hepatocellular carcinoma (HCC)
    Zendeh, D
    Holle, A
    Liebe, S
    MEDIZINISCHE WELT, 1998, 49 (10): : 489 - 498
  • [6] Assessment of prognosis in hepatocellular carcinoma (HCC) using biomarkers and serum measurements
    Teng, Mabel Joey
    Nathavitharana, Ravindhi Lakmalee
    Fox, Richard
    Berhane, Sarah
    Skowronska, Anna
    Johnson, Philip James
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
    Yu, Baofa
    Ma, Wenxue
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 79 : 29 - 38
  • [8] HEPATOCELLULAR CARCINOMA (HCC)
    Villanueva, A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Hepatobiliary MR Contrast Agents in Hypovascular Hepatocellular Carcinoma
    Motosugi, Utaroh
    Bannas, Peter
    Sano, Katsuhiro
    Reeder, Scott. B.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 41 (02) : 251 - 265
  • [10] Treatment not needed for hypovascular tumors associated with hepatocellular carcinoma
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    HEPATOLOGY, 2015, 62 : 415A - 416A
12345